PROCESS FOR THE PREPARATION OF NEW MUTANTS OF HERPES VIRUSES, TYPE 1 AND TYPE 2, MUTANTS OBTAINED AND THEIR APPLICATION TO THE MANUFACTURE OF VACCINES AGAINST HERPETIC INFECTIONS

摘要

HERPES VIRUSES ARE SUBJECT TO DOUBLE TRANSFER BY TREATMENT WITH PHOSPHONOFORMIC ACID AND 5-ETHYL-2-DESOXYURIDINE (IN TWO PHASES). OF THE KIND, THE PATHOGENIC CHARACTERISTICS OF HERPES VIRUSES HAVE BEEN SUFFICIENTLY SUFFICIENT SO THAT THEY CAN BE USED AS VACCINES FOR HERPETIC INFECTIONS.